R. LaDuane Clifton - 31 Dec 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Former CFO & Treasurer
Signature
/s/ R. LaDuane Clifton
Issuer symbol
ZVRA
Transactions as of
31 Dec 2025
Net transactions value
-$434,676
Form type
4
Filing time
07 Jan 2026, 16:18:01 UTC
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clifton R. LaDuane Former CFO & Treasurer C/O ZEVRA THERAPEUTICS, INC., 1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION /s/ R. LaDuane Clifton 07 Jan 2026 0001488774

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Options Exercise $0 +140,667 +274% $0.000000 192,028 31 Dec 2025 Direct F1
transaction ZVRA Common Stock Tax liability $434,676 -48,513 -25% $8.96 143,515 31 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Restricted Stock Unit Options Exercise $0 -86,667 -100% $0.000000 0 31 Dec 2025 Common Stock 86,667 Direct F3, F4
transaction ZVRA Restricted Stock Unit Options Exercise $0 -34,000 -100% $0.000000 0 31 Dec 2025 Common Stock 34,000 Direct F3, F4
transaction ZVRA Performance Stock Unit Options Exercise $0 -20,000 -100% $0.000000 0 31 Dec 2025 Common Stock 20,000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

R. LaDuane Clifton is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.
F2 Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.
F5 Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.